Regulatory and microbiological safety issues surrounding cell and tissue-engineering products

Biotechnology and Applied Biochemistry

Volumn 40, Issue 1, 2004, Pages 35-39

  Galbraith, Daniel N ^a  

^a BioReliance   (United Kingdom)

Author keywords

Contamination of tissue engineered products; Human cell therapy; Viral risk

Indexed keywords

CELLS; PRODUCT DESIGN; RAW MATERIALS; RISK ASSESSMENT; TESTING; TISSUE; VIRUSES;

PRODUCT TESTING; SAFETY ISSUES; THERAPEUTIC PRODUCTS;

MICROBIOLOGY;

ADOPTIVE IMMUNOTHERAPY; BURN; FIBROBLAST; HUMAN; KERATINOCYTE; MICROBIOLOGICAL EXAMINATION; RISK ASSESSMENT; SHELF LIFE; SHORT SURVEY; SKIN TRANSPLANTATION; SKIN ULCER; TISSUE ENGINEERING; VIRUS TRANSMISSION;

CONSUMER PRODUCT SAFETY; DISEASE TRANSMISSION; HUMANS; MICROBIOLOGICAL TECHNIQUES; PRODUCT SURVEILLANCE, POSTMARKETING; QUALITY ASSURANCE, HEALTH CARE; RISK ASSESSMENT; SKIN, ARTIFICIAL; TISSUE ENGINEERING; TISSUE THERAPY; UNITED STATES;

EID: 4043133088     PISSN: 08854513     EISSN: None     Source Type: Journal    
DOI: 10.1042/BA20030163     Document Type: Short Survey

References (25)

1. Miller, M. J. and Patrick, Jr, C. W. (2003) Clin. Plast. Surg. 30, 91-103
2. U.S. Food and Drugs Administration (1999) CFR (Code of Federal Regulations) section 1271 Subpart C - Suitability Determination for Donors of Human Cellular and Tissue Based Products, Proposed rule 64 FR 189, 30 September 1999, U.S. Food and Drugs Administration, Rockville, MD
3. Hitzler, W. E. and Runkel, S. (2001) Clin. Lab. 47, 219-222
4. Schreiber, G. B., Busch, M. P., Kleinman, S. H. and Korelitz, J. J. (1996) N. Engl. J. Med. 334, 1685-1690
5. Kashanchi, F., Melpolder, J. C., Epstein, J. S. and Sadaie, M. R. (1997) J. Med. Virol. 52, 179-189
6. Takeuchi, H., Kobayashi, R., Hasegawa, M. and Hirai, K. (1996) J. Virol. Methods 58, 81-89
7. Valantine, H. A. (1999) Transpl. Infect. Dis. 1, 25-30
8. Burke, D. S. and Monath, T. P. (2001) in Fields Virology (Knipe, D. M. and Howley, P. M., eds.-in-chief), pp. 1043-1125, Lippincott Williams & Wilkins, Philadelphia
9. Hawkey, P. M. Bhagani, S. and Gillespie, S. H. (2003) J. Med. Microbiol. 52, 609-613
10. Hadaway, L. C. (2003) J. Infus. Nurs. 26, 44-48
11. Galbraith, D. W., Anderson, M. T. and Herzenberg, L. A. (1999) Methods Cell Biol. 58, 315-341
12. European Medicines Evaluation Agency (2002) Note for Guidance on the Production and Quality Control of Animal Immunoglobulins and Immunosera for Human Use, Publication no. CPMP/BWP/3354/99, European Medicines Evaluation Agency, Canary Wharf, London
13. European Medicines Evaluation Agency (2003) Note for Guidance on the Use of Bovine Serum in the Manufacture of Human Biological Medicinal Products, Publication no. CPMP/BWP/1793/02, European Medicines Evaluation Agency, Canary Wharf, London
14. European Pharmacopoeia (2004) European Pharmacopoeia, section 2.6.1 (Sterility), Maisonneuve SA Sainte Ruffine
15. The United States Pharmacopeial Convention (2004) United States Pharmacopeia, chapter 71, The United States Pharmacopeial Convention, Rockville, MD
16. European Pharmacopoeia (2004) European Pharmacopoeia, section 2.6.7 (Mycoplasma), Maisonneuve SA, Sainte Ruffine
17. Uphoff, C. C. and Drexler, H. G. (1999) Hum. Cell 12, 229-236
18. Tang, J., Hu, M., Lee, S. and Roblin, R. (2000) J. Microbiol. Methods 39, 121-126
19. Harasawa, R., Mizusawa, H., Nozawa, K., Nakagawa, T., Asada, K. and Kato, I. (1993) Res. Microbiol. 144, 489-493
20. European Medicines Evaluation Agency (1997) ICH Consensus Guideline on Quality Of Biotechnology Products: Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin, Publication no. CPMP/ICH/295/95, European Medicines Evaluation Agency, Canary Wharf, London
21. Laassri, M., Chizhikov, K., Mikheev, M., Shchelkunov, S. and Chumakov, K. (2003) J. Virol. Methods 112, 67-78
22. Oshima, H., Inoue, H., Matsuzaki, K., Tanabe, M. and Kumagai, N. (2002) Hum. Cell 15, 118-128
23. Fowler, M. G. (1997) Curr. Opin. Obstet. Gynecol. 9, 343-348
24. Murakami, J., Okamoto, M., Miyata, H., Nagata, I., Shiraki, K. and Hino, S. (2000) Pediatr. Res. 48, 450-456
25. Lipitz, S., Achiron, R., Zalel, Y., Mendelson, E., Tepperberg, M. and Gamzu, R. (2002) Obstet. Gynecol. 100, 428-433